Filing Flows › Companies › Zymeworks › Report card
Zymeworks earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate1 of 4 reports beat the EPS estimate
Zymeworks (ZYME) beat the analysts' EPS estimate in 1 of its last 4 reports (25%), by -135.5% on average. On report days the stock moved 8.8% in either direction on median (largest 13.5%), rising 50% of the time. Next report: Nov 9, 2026, analysts expect EPS $2.19.
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise | GAAP EPS | Revenue reported | Stock, the day | vs market |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | −$0.59 | −$0.62 | -4.8% | −$0.62 | $4.6M | +0.2% | -0.3% |
| Q1 2026 | May 7, 2026 | −$0.10 | −$0.59 | -484.3% | −$0.59 | $2.4M | -13.5% | -14.0% |
| Q4 2025 | Mar 2, 2026 | −$0.32 | −$0.55 | -70.6% | — | $2.5M | +5.0% | +5.8% |
| Q3 2025 | Nov 6, 2025 | −$0.32 | −$0.26 | +17.8% | −$0.26 | $27.6M | -8.8% | -7.8% |
Estimates and reported EPS are the Street's adjusted figures; GAAP EPS is from the filing (SEC XBRL). Revenue reported is from the company's filing. The stock's move is close to close around the report date (the close before it to the close of the session after), against SPY for the market column.
Charts
The earnings-day move
Over 4 reports the stock moved 8.8% on median on the day (close to close), the largest move 13.5%.
The next report: what to expect → Zymeworks: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.